Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
131.68
-3.32 (-2.46%)
At close: Nov 20, 2024, 4:00 PM
131.83
+0.15 (0.11%)
After-hours: Nov 20, 2024, 4:13 PM EST
Illumina Revenue
Illumina had revenue of $1.08B in the quarter ending September 29, 2024, a decrease of -3.49%. This brings the company's revenue in the last twelve months to $4.39B, down -1.68% year-over-year. In the year 2023, Illumina had annual revenue of $4.50B, down -1.75%.
Revenue (ttm)
$4.39B
Revenue Growth
-1.68%
P/S Ratio
4.76
Revenue / Employee
$328,593
Employees
13,360
Market Cap
20.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Dec 28, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Koninklijke Philips | 20.12B |
Labcorp Holdings | 12.71B |
Biogen | 9.61B |
Zimmer Biomet Holdings | 7.60B |
STERIS | 5.33B |
The Cooper Companies | 3.80B |
BeiGene | 3.35B |
Waters | 2.91B |
ILMN News
- 19 hours ago - Illumina, Inc. (ILMN) CFO Ankur Dhingra Hosts Wolfe Research 2024 Healthcare Conference (Transcript) - Seeking Alpha
- 2 days ago - Illumina announces expansion of TruSight Oncology portfolio - PRNewsWire
- 14 days ago - Illumina To Webcast Upcoming Investor Conferences - PRNewsWire
- 15 days ago - Illumina: Q3 Confirms Improving Fundamentals - Seeking Alpha
- 16 days ago - Illumina, Inc. (ILMN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 - PRNewsWire
- 21 days ago - Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting - PRNewsWire
- 6 weeks ago - Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers - PRNewsWire